Special Issue: Advances in Molecular Medicine

Cancer Biotherapy and Radiopharmaceuticals is a multidisciplinary peer-reviewed journal covering all aspects of radiopharmaceutical research, as well as biotechnology. The journal provides a high-profile platform for international original research papers, as well as comprehensive review articles, rapid communications, brief reports, protocols, technology reports, mini reviews, and rapid communications.

Cancer Biotherapy and Radiopharmaceuticals publishes original research addressing all aspects of radiopharmaceutical science. Contributions to this topic broadly includes the synthesis and characterization, in vitro studies, in vivo biodistribution and targeting validation studies, and in vivo research studies that support translational clinical studies of new targeted radiotracers, imaging agents, radiotherapeutic agents. Manuscripts on all these aspects of radiopharmaceutical research with an emphasis on applications in the area of cancer research are appropriate.  

This special issue, "Advances in Molecular Medicine," is framed in the context of the most recent discoveries and achievements in biomedical research, which together with the modern technological and applicative advances in medicine, are evolving towards a revolutionary approach to understanding human diseases and discovering new therapeutic methods. The study of the molecular and cellular mechanisms that regulate complex systems requires an intense interaction between basic and applied research. Translational medicine combines biomedical skills and advancements in basic research with clinical reality. For this special issue, original and observational studies, as well as reviews, clinical cases, and proof-of concepts in the broad fields of laboratory, clinical and health research, are welcomed.

Areas of focus include, but are not limited, to: 

• Molecular pathology
• Biomarkers
• Signature transduction
• Cell signaling
• Molecular mechanisms
• Translational research
• Pathophysiology
• Molecular tumor pathology
• Tumor microenvironment
• Cancer epidemiology and prevention
• Cancer biomarkers: screening, diagnosis, treatment response, prognosis
• Cancer therapy: target discovery, drug design, resistance, targeted therapy, theragnostic, personalized medicine
• Translational cancer research
• High-throughput technologies: genomics, epigenomics, proteomics, metabolomics, microarray, next generation sequencing, and other omics technologies
• Genomic and proteomic databases and applications

Scope: 

• Disease mechanisms
• Tools and technologies
• Diagnostics
• Therapeutics
• Clinical Diagnostic
• Clinical Medicine
• Cancer Research
• Diabetes
• Cancer biomarker, cancer clone
• Cancer functional pathway
• Cancer gene therapy
• Cancer master regulator
• Cancer stem cell theory
• Cancer targeted therapy
• Cancer immunotherapy

Contributions will receive prompt and thorough peer review.